Summary of findings 3. Treatment of relapsed/recurrent congenital talipes equinovarus (CTEV; clubfoot).

Patient or population: participants with relapsed or recurrent CTEV Settings: ‐ Intervention: ‐ Comparison: ‐
Outcomes	Illustrative comparative risks* (95% CI)		Relative effect (95% CI)	No of Participants (studies)	Quality of the evidence (GRADE)	Comments
	Assumed risk	Corresponding risk
Function	No trials assessed treatments for relapsed or recurrent CTEV.
Foot alignment
Gait assessment
Health‐related quality of life
Adverse events
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: confidence interval; RR: risk ratio
GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate.